US Patent US 20110212975. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite?

Abstract

Compounds which exhibit antiviral activity, particularly against influenza virus, and methods of making and using thereof are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteral or parenteral administration. The compounds are preferably used to treat or prevent Influenza A infections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.

US Patent US 20110212975. Washington, DC: US Patent and Trademark Office (USPTO), 2011

-

dc.identifier.uri

http://hdl.handle.net/10722/210530

-

dc.description.abstract

Compounds which exhibit antiviral activity, particularly against influenza virus, and methods of making and using thereof are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteral or parenteral administration. The compounds are preferably used to treat or prevent Influenza A infections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.

-

dc.relation.isreferencedby

US 2012245176 (A1) 2012-09-27

-

dc.relation.isreferencedby

WO 2014086704 (A1) 2014-06-12

-

dc.rights

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.